Skip to main content
An official website of the United States government

Chemopreventive Agent Development

Designs, develops, implements, and monitors research on interventions that may block, reverse, or delay the early stages of cancer. Investigates nutrients, micronutrients, natural products, pharmacologic agents, biomolecules, and vaccines from preclinical to early-phase I clinical studies. Helps investigators to bridge the gaps between biology and identifying potential targets, and between discovery of targets and agents and clinical testing in people.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

Major Programs

Staff List

Photo Name, Email, Phone Room Group(s)/Office
Asefa, Wosene
wosene.asefa@nih.gov
240-276-6422
5E504 Program Support Assistant | Chemopreventive Agent Development
Biswas, Kajal, Ph.D.
kajal.biswas2@nih.gov
240-276-5614
5E540 Program Officer | Chemopreventive Agent Development
Cholewa, Brian, Ph.D.
brian.cholewa@nih.gov
240-276-7545
5E446 Deputy Chief | Chemopreventive Agent Development
Clifford, John, Ph.D.
john.clifford@nih.gov
202-235-4482
5E430 Program Officer | Chemopreventive Agent Development
Gunasekharan, Vignesh, Ph.D.
vignesh.gunasekharan@nih.gov
240-276-5814
5E438 Program Officer | Chemopreventive Agent Development
Mohammed, Altaf, Ph.D.
altaf.mohammed@nih.gov
240-276-6082
5E542 Deputy Chief | Chemopreventive Agent Development
Nalli, Ancy, Ph.D., M.S.
ancy.nalli@nih.gov
202-276-5265
5E536 Program Officer | Chemopreventive Agent Development
Sei, Shizuko, M.D.
shizuko.sei@nih.gov
240-276-5005
5E452 Co-Chief | Chemopreventive Agent Development
Shoemaker, Robert, Ph.D.
robert.shoemaker@nih.gov
240-276-7077
5E454 Co-Chief | Chemopreventive Agent Development
Acting Chief | Nutritional Science
Vlad, Anda, M.D., Ph.D.
anda.vlad@nih.gov
240-276-6422
5E538 Program Officer | Chemopreventive Agent Development

Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Pozdeyev, Nikita

University Of Colorado Denver
United States

Genetic architecture of thyroid cancer and its clinical utility 5R21CA282380-02 Wendy Wang, Ph.D., M.Sc.
Prigerson, Holly Gwen

Weill Medical Coll Of Cornell Univ
United States

Behavioral and Psychosocial Effects on Study Outcomes in End-Stage Cancer Treatment (BEST End-Stage Cancer Study) 5R35CA197730-11 Brennan Streck, Ph.D., RN, M.P.H.
Punnen, Sanoj

University Of Miami School Of Medicine
United States

The Rigor and Clinical Utility of PSMA Enriched Extracellular Vesicles for Prostate Cancer Detection 5R01CA272766-03 Matthew Young, Ph.D.
Pyter, Leah M

Ohio State University
United States

Chemotherapy-induced circadian master clock disruptions and fatigue 3R01CA270372-03S1 Marjorie Perloff, M.D.
Rajagopalan, Malolan S

Columbus Community Clinical Oncology Prg
United States

Columbus NCORP RFA-CA-18-016 3UG1CA189954-11S1 Vanessa A. White, M.P.H.
Rajkumar, S Vincent

Mayo Clinic Rochester
United States

Onset and biomarkers for progression of monoclonal gammopathies 5R01CA168762-11 Nicholas Hodges, Ph.D.
Ramanujam, Nirmala

Duke University
United States

Development and Validation of an Artificial-Intelligence-enabled Portable Colposcopy Device for Optimizing Triage Alternatives for HPV-based Cervical Cancer Screening 3U01CA269192-04S1 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Rao, Chinthalapally V.

University Of Oklahoma Hlth Sciences Ctr
United States

Discovery and Development of Natural Products for Interception of CRC 5UG3CA290310-02 Kajal Biswas, Ph.D.
Reb, Anne

Beckman Research Institute/City Of Hope
United States

A Blended e-Health Intervention for Fear of Progression in Advanced GYN Cancer 1R21CA293326-01 Brennan Streck, Ph.D., RN, M.P.H.
Reese, Jennifer Barsky

Research Inst Of Fox Chase Can Ctr
United States

Promoting Effective Clinical Communication about Sexual Health after Gynecologic Cancer: A Randomized Controlled Trial of a Patient-Focused Intervention 5R01CA285674-02 Vanessa A. White, M.P.H.
Remick, Scot C

Mainehealth
United States

MaineHealth Cancer Care Network (MHCCN) and NCORP Activities across the Lifespan 3UG1CA239771-06S1 Vanessa A. White, M.P.H.
Reuland, Daniel S.

Univ Of North Carolina Chapel Hill
United States

Administrative Supplement: CSRN Vanguard Study 3UG1CA286949-02S1 Elyse LeeVan, M.D., M.P.H.
Richards-Kortum, Rebecca R.

Rice University
United States

Low-cost mobile colposcopy and confocal imaging for global prevention of cervical cancer 5R01CA251911-05 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Richards-Kortum, Rebecca R.

Rice University
United States

Sample-to-answer HPV DNA nucleic acid test for cervical cancer screening in Mozambique 3U01CA292741-02S1 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Rini, Christine

Northwestern University At Chicago
United States

Mosaic: RCT of a Digital Health Intervention Delivering Peer Support Narratives and Psychoeducation to English- and Spanish-Speaking Stem Cell Transplant Recipients 5R01CA292116-02 Brennan Streck, Ph.D., RN, M.P.H.